The SEED-AD Research Program in the Women's Health Research Center at Mayo Clinic studies how removal of the ovaries affects ...
The FDA has authorized Mayo Clinic to offer mesenchymal stem cells as part of the Regenerative Nephrology Compassionate Use Program. This is an expanded access program.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback